"I am a better investor because I am a businessman, and a better businessman because I am an investor."..Warren Buffet.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Groupe Athena, Inc. Clarifies Previous Guidance, Addresses U.S. Drug Shortage
Groupe Athena (PC) (USOTC:GATA)
Today : Saturday 3 March 2012
Groupe Athena, Inc. (Pink sheets GATA.PK)
The guidance contained below represents forecasts, which indicate possible outcomes and are provided to assist investors with the development of earnings estimates. While Groupe Athena, Inc. believes that these forecasts represent the best estimate of management as to future events, actual events may differ from these forecasts, and such differences could be material. These forecasts are subject to risks identified under "Safe Harbor Statement" below.
Groupe Athena, Inc. (Pink sheets GATA.PK) has previously announced they have approximately $60 million in customer orders that they are processing and they expect to be able to convert at least two thirds or approximately $40 million into revenue for the current fiscal year. The company is extremely pleased to issue this guidance update and announce that due to several factors including additional order flow and the recent equipment acquisitions, revenue should increase at least 10% or a minimum of $4 million. Earnings are also expected to increase similarly.
The company also announced they are in talks with several regional drug manufacturers as part of an effort to help alleviate the recently announced severe, potentially life threatening shortage of vital cancer drugs in the United States including methatrexate, one of the most widely used. The company expects developments in the near term and has committed to make every effort to "fast track" any trials or regulatory filings necessary.
The Indian pharmaceutical industry is increasingly focusing on exports to the United States and GATA is well positioned to help them get their products approved by the FDA for sales in the US. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation. With recent additions to equipment, the company will continue to take on additional contracts and continue to anticipate further growth.
About Groupe Athena, Inc.
Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.
The company has a research and marketing facility in India that currently employs 16 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company's web address is www.groupeathena.com.
For more information contact:Paul CornellCorporate Shareholder Relations, Inc.pcornell@totalpublicrelations.com
GATA - Daily Candlesticks
GATA - Groupe Athena, Inc. Clarifies Previous Guidance, Addresses U.S. Drug Shortage
Groupe Athena (PC) (USOTC:GATA)
Today : Saturday 3 March 2012
Groupe Athena, Inc. (Pink sheets GATA.PK)
The guidance contained below represents forecasts, which indicate possible outcomes and are provided to assist investors with the development of earnings estimates. While Groupe Athena, Inc. believes that these forecasts represent the best estimate of management as to future events, actual events may differ from these forecasts, and such differences could be material. These forecasts are subject to risks identified under "Safe Harbor Statement" below.
Groupe Athena, Inc. (Pink sheets GATA.PK) has previously announced they have approximately $60 million in customer orders that they are processing and they expect to be able to convert at least two thirds or approximately $40 million into revenue for the current fiscal year. The company is extremely pleased to issue this guidance update and announce that due to several factors including additional order flow and the recent equipment acquisitions, revenue should increase at least 10% or a minimum of $4 million. Earnings are also expected to increase similarly.
The company also announced they are in talks with several regional drug manufacturers as part of an effort to help alleviate the recently announced severe, potentially life threatening shortage of vital cancer drugs in the United States including methatrexate, one of the most widely used. The company expects developments in the near term and has committed to make every effort to "fast track" any trials or regulatory filings necessary.
The Indian pharmaceutical industry is increasingly focusing on exports to the United States and GATA is well positioned to help them get their products approved by the FDA for sales in the US. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation. With recent additions to equipment, the company will continue to take on additional contracts and continue to anticipate further growth.
About Groupe Athena, Inc.
Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.
The company has a research and marketing facility in India that currently employs 16 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company's web address is www.groupeathena.com.
For more information contact:Paul CornellCorporate Shareholder Relations, Inc.pcornell@totalpublicrelations.com
Really? No clue. I know this GATA is getting tons of chatter...I will watch your one as well. GLTY
GATA!! News out yesterday!! Groupe Athena, Inc. (Pink sheets GATA.PK) has previously announced they have approximately $60 million in customer orders that they are processing and they expect to be able to convert at least two thirds or approximately $40 million into revenue for the current fiscal year. The company is extremely pleased to issue this guidance update and announce that due to several factors including additional order flow and the recent equipment acquisitions, revenue should increase at least 10% or a minimum of $4 million. Earnings are also expected to increase similarly.
GATA news out yesterday!! Groupe Athena, Inc. (Pink sheets GATA.PK) has previously announced they have approximately $60 million in customer orders that they are processing and they expect to be able to convert at least two thirds or approximately $40 million into revenue for the current fiscal year. The company is extremely pleased to issue this guidance update and announce that due to several factors including additional order flow and the recent equipment acquisitions, revenue should increase at least 10% or a minimum of $4 million. Earnings are also expected to increase similarly.
I hope so. Get in load up and make some $$$$. This is long legs.
I love it when they drop the A/S...this is one I need to sit bid on.
Hey Champ, good to see you here. IMHO, GWIV is just getting started.,..I am accumulating down here,...I say down here because this has legs that are just getting under it,....Look at OTC and you will see the filings are all current and that this OTCQB is just waking up. Looks like the company is all about telling the story to the market. Link is here...
http://www.otcmarkets.com/stock/GWIV/quote
GM All, GWIV is all the talk in some skype rooms I am in. Looks like the volume only increases from here, which means that the PPS is likely to follow!!
NP Pastor, happy to help this group.
It all makes sense now. GWIV 4M float...no selling....this is too thin. Looks I am upping to a junior pack from my starter pack.
Mods, please make post # 382 a sticky!! TIA!!
I have the up to date SS as of ten seconds ago,...here it is...
Standard Registrar and Transfer Co., Inc.
I spoke to Rachel.
12528 South 1840 E.
Draper, UT, 84020
801-571-8844
GWIV
A/S = 50,000,000
O/S = 32,590,850
Float = 4,496,000
Talk about a low floater with MAX upside!!
GWIV...L2 shows 1700 shares to $5.00. I know that cannot be the case, but it shows how very thin this one is.
GWIV..1K shares takes out $1.73...this is getting really warm, really fast!!
Just called. They are not open yet. I left a message to call me, but I think I will be proactive and send an email inquiry as well. Update the board with what I find out.
Hey Tommyboy, I will call them for the updated SS. Hopefully they are not gagged and will give us the skinny!!
Hey Tommy, this is indeed crazy. I never thought we had 12K shares coming back today. This is going to clear out the $1.70's.
Managemenet is not drawing any form of compensation as well. A clear sign they are behind this plan big time.
This is from the company's most recent 10-K
Item 11.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8364079
Hey jet, GWIV could hit $1.70 in a half hour. I have not seen a thin box like this in a few years on BB security.
GWIV..link to filings on this low floater OTCQB Security
http://www.otcmarkets.com/stock/GWIV/financials
GWIV Tommyboy, looks like we got our upside this morning in a big way.
GWIV Filing....only 32M O/S...this is crazy low floater...link is here
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8422391
GM All...thin to win, GWIV is so thin...1K shares took out the $1.50's.
Herborium Group to Begin Commercialization of its All Natural Sexual Health Products With Aggressive Plans to Take a Bite of a 3.2 Billion Dollar Market
Herborium to sell products for both Men and Women based on Traditional Chinese Medicine with a 98% efficacy rate with no side effects
Press Release: Herborium Group, Inc. – 2 hours 22 minutes ago.. .
.
TEANECK, N.J., March 1, 2012 /PRNewswire/ -- Herborium Group, Inc., (Pink Sheets: HBRM) www.herborium.com, a Botanical Therapeutics® company, announce today a plan to commercialize its sexual health proprietary Botanical Therapeutics® in 2012. The market for pharmaceutical grade sexual health products is over 3.2 billion worldwide with Viagra (Pfizer), Cialis (Eli Lilly) and Levitra (Bayer) leading market share. The market for natural sexual health products is estimated to be over $1.5 billion and growing. The rising costs of pharmaceutical grade sexual health drugs together with some safety concerns drive consumers to look for alternatives in the market for natural sexual health products.
In addition there is a growing need for women sexual health products. In fact the female sexual enhancement industry is expected to grow into a multibillion dollar business. Long considered a taboo subject, women's sexuality is now openly discussed and portrayed on television, in magazines, and on the internet. Most importantly, women themselves are becoming increasingly aware of their sexuality and their sexual health. First-quarter sales of personal lubricants soared 32% to $41.2 million, according to Information Resources Inc. There is no Viagra comparative product on the market for women.
Dr. Agnes Olszewski, Chairman and CEO of Herborium, stated: "We believe that this is the right time to commercialize our all herbal, proprietary products for men and women. There is nothing on the market as our systemic all herbal product for women. Unlike many supplements claiming to improve sexual performance and libido both our products include only herbal ingredients recognized for their safety. Both products developed by Herborium are based on a combination of Principles of Traditional Chinese Medicine and modern sexual health science, have confirmed up to 98% efficacy and improve performance and experience for those men and women with sexual performance problems and those seeking recreational sexual enhancement. Products have no know adverse effects."
"By combining unique characteristics of Herborium sexual health Botanical Therapeutics® with our social media marketing strategy and growing demand and awareness regarding sexual health, we expect our products to gain market acceptance and revenue generating status in 2012," concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com
Tommy, when GWIV goes IMHO, it is gonna go BIGLY!! The current activity has me thinking this could see $2.00 before it really lifts off....GLTY...Have a great night.
GWIV..About GlobalWise Investments, Inc.
GlobalWise Investments, Inc., via its wholly owned subsidiary Intellinetics, Inc., is a Columbus, Ohio based Enterprise Content Management (ECM) pioneer with industry-leading software that delivers cloud ECM based solutions on-demand. The Company's flagship platform, Intellivue™, represents a new industry benchmark and game-changing solution by enabling clients to access and manage the content of every scanned document, file, spreadsheet, email, photo, audio file or video tape -- virtually anything that can be digitized -- in their enterprise from any PC, laptop, tablet or smartphone from anywhere in the world.
For additional information, please visit the Company's corporate website: http://www.GlobalWiseInvestments.com
GWIV...Today, with the Company's technology migration to the "cloud" complete, Intellinetics is rapidly becoming an aggressive player in the growing ECM industry, which Gartner estimates will exceed $5.7 billion by 2014 with compounded annual growth rates of 10.1%. The Intellivue™ ECM platform is now being distributed through a variety of direct sales and value-added resellers or channels throughout the private and public sectors. Leveraging its industry leading position, Intellinetics will capture emerging growth opportunities by driving the ECM economic benefits to the private and public sectors in the underserved small-to-mid sized business market.
GWIV..From 2001 through 2007, Intellinetics continued to focus on software development, refinement, customer expansion and increasing sales. From 2007 through the beginning of 2010, Intellinetics was awarded two Ohio Innovation Loans to accelerate its software migration from a more traditional client-server premise-based solution to Web-based services optimized for cloud delivery. This transformation is foundational to Intellinetics' success and timing. As the proliferation of "smartphone" mobile devices were becoming a more viable business tool, the Intellinetics software was being optimized for access from any Internet-enabled hardware device
GWIV..From mid-1990 to early 2000, Intellinetics focused on business "intelligence" and developed industry-first redaction-enabled technology for the Ohio State Highway Patrol, a development that garnered national recognition. This new redaction-enabled software won the Technology Award of Excellence and continued the Company's software development path toward an ECM system that could be used as an enterprise-wide document management solution. During this formation timeframe, the Intellinetics customer base evolved beyond law enforcement to government contracts and commercial clients.
GWIV...In 1994, father and son founders Michael and Matthew Chretien formed Intellinetics, Inc. in Columbus, Ohio. Leveraging Michael's 25-year law enforcement career combined with Matthew's IT and operational backgrounds, Intellinetics provided IT consulting, document storage systems and project-specific software development. In 1995, the entrepreneurs won their first consulting contract with the Ohio State Highway Patrol to provide a more sophisticated solution to their 1950s era records management system. This marked the beginning of the modern-day Intellinetics, which began to transition itself from records content storage consulting toward becoming a software development firm focused on enterprise-wide content management.
Through its cloud-based Intellivue™ product line and unique Channel / OEM distribution model, Intellinetics is prepared to dominate in the underserved small-to-mid sized business marketplace. The Company's position reflects the entrepreneurial vision and innovation of its founders, which served as catalysts for Intellinetics' evolution from an early pioneer to a recognizable player in the ECM industry.
GWIV...The Intellinetics' flagship ECM platform, Intellivue™, represents a new industry benchmark in making the promise of ECM a simple to attain, affordable reality by combining the power of the Cloud with on-demand solution templates and user-focused design. Intellivue™ provides clients with the ability to access and manage every piece of content they produce or receive, including but not limited to paper documents, digital content, database print streams and e-mail. The data is accessible from virtually any PC, laptop, tablet or smartphone from anywhere in the world.
Just got back in...this is more like it...I knew GWIV had some momo coming...look at the volume increase...this is a nice steady walk up....awesome...GLTA
Hey tommyboy, good to see you here. Thanks for the L2 information. I see this as a $1.75 easy PPS down the road...